Cargando…

Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease

OBJECTIVE: This study was mainly conducted to explore the expression changes of GSDMD and conventional markers (including T‐Tau, Tau181p, and Aβ(1–42)) in the cerebrospinal fluid among patients with Alzheimer's disease (AD) and vascular dementia (VD), followed by determination of role of GSDMD...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Heping, Han, Chenyang, Yang, Yi, Guo, Li, Sheng, Yongjia, Wang, Jin, Li, Wenyan, Zhai, Liping, Wang, Genghuan, Guan, Qiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035446/
https://www.ncbi.nlm.nih.gov/pubmed/33587329
http://dx.doi.org/10.1002/brb3.2063